Accuray Incorporated is the premier radiation oncology company that develops, manufactures and sells personalized innovative treatment solutions that set the standard of care, with the aim of helping cancer patients live longer, better lives. The Company’s leading edge technologies – the CyberKnife® System and TomoTherapy® Systems – are designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. Accuray is headquartered in Sunnyvale, CA.
Accuray does not assume a duty to update information on this website, except through the normal quarterly financial press releases and regulatory filings.
Conference Presentations Highlighted Benefits of the CyberKnife® System’s Motion Management and the TomoTherapy® System’s Daily Image-Guidance
SUNNYVALE, Calif., May 16, 2012 – Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that for the first time in Europe, at ESTRO 31, the Annual Congress of the European Society for Therapeutic Radiology and Oncology in Barcelona, Spain, the company showcased side-by-side the CyberKnife® Robotic Radiosurgery Syste...
SUNNYVALE, Calif., May 15, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the B. Riley & Company 13th Annual Investor Conference in Los Angeles on Wednesday, May 23, 2012 at 11:30 a.m. PDT/2:30 p.m. EDT.
A live webcast of the presentations will be available online from the Investor Relations page of the Company's website at http://www.accuray.com. The webcast replay of the ...
New VoLO™ Technology Delivers Greater Efficiency and Flexibility in Complex Treatment Planning; Demonstrates Accuray's Ongoing Commitment to Advancing Radiation Oncology
SUNNYVALE, Calif., May 9, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the availability of VoLO™ Technology for the TomoTherapy® System, a new treatment planning system that leverages advanced graphics processing technology and a new calc...
Continued Service Margin Improvement Highlights Quarter
SUNNYVALE, Calif., May 8, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today financial results for the third quarter of fiscal 2012 that ended March 31, 2012. The fiscal 2012 financial data presented below reflects Accuray's consolidated results including the results for TomoTherapy which was acquired by Accuray in June 2011. Non-GAAP results are provided to enhance understan...
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Some documents in the Investor Relations section require that you have Adobe Acrobat Reader® installed in order to view files in PDF format. Download the newest version of Acrobat Reader.
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
